PHP-303

DRUG2 trials

Sponsors

pH Pharma

Conditions

Healthy VolunteerOtherwise Healthy Overweight or Obese

Phase 1

A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects

CompletedNCT03627845

pH PharmaHealthy Volunteer

Start: 2018-08-02End: 2020-01-08Updated: 2020-04-13

A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of PHP-303 in Otherwise Healthy Overweight or Obese Subjects

CompletedNCT03775278

pH PharmaOtherwise Healthy Overweight or Obese

Start: 2018-12-17End: 2020-04-07Updated: 2020-04-13